Deferasirox Tablet, For Suspension
Product Images NDC 43598-856

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 43598-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Deferasirox Tablets for Oral Suspension 125 mg per tablet in a blister card format. The label includes dosing storage instructions, a note that tablets must be dispersed before ingestion, and a warning to keep medications out of reach of children. It is manufactured and distributed by Dr. Reddy's Laboratories Inc. The package contains 30 tablets.*

FDA Label Image

Container2 (Container2)

Label for Deferasirox Tablets for Oral Suspension 250 mg per tablet by Dr. Reddy's Laboratories Inc. The label includes dosage and storage instructions, a barcode, and a quantity statement indicating 30 tablets. It also advises that tablets must be dispersed before ingestion and provides pharmacist dispensing guidance.*

FDA Label Image

Container3 (Container3)

Label for Deferasirox Tablets for Oral Suspension 500 mg per tablet by Dr. Reddy's Laboratories Inc. The label includes dosage storage instructions, a warning to disperse tablets in water, orange, or apple juice prior to ingestion, and packaging quantity of 30 tablets. Distributed by Dr. Reddy's Laboratories Inc., made in India.*

FDA Label Image

Fig-01 (Deferasirox Figure 1)

A bar chart depicting changes in liver iron content, serum ferritin, and serum ferritin levels in relation to different doses (5, 10, 20, 30 mg/kg/day) of Deferasirox tablets. The chart shows the effects of increasing Deferasirox doses on these parameters, with error bars indicating variability.*

FDA Label Image

Str (Deferasirox Structure)

Chemical structure diagram of Deferasirox, illustrating its molecular framework with multiple aromatic rings and functional groups as part of its active ingredient representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.